Biogen Inc. (BIIB)

Healthcare
$191.66▼ 2.72 (1.40%)
Real-time prices · US Markets
📅
Next earnings: Jul 30
Q·Score
Buy
7.5 / 10
Clean balance sheet with low leverage (0.4× debt-to-equity).
Quality
7
Health
9.7
Growth
7.8
Valuation
6.4
Sentiment
6.4
Analyst Target
$212.51
▲ +10.9% from current

Price Chart

Fundamentals

Trailing P/E
20.6×
price-to-earnings
Forward P/E
12.0×
next 12 months est.
Market Cap
$28.3B
market capitalization
Div Yield
dividend yield
Profit Margin
13.8%
net profit margin
Gross Margin
78.7%
revenue minus COGS
ROE
7.7%
return on equity
Beta
0.16
vs S&P 500
Price / Book
P/B ratio
52-Week Range
$115 — $202
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

Is BIIB a good stock to buy right now?
Based on our Q·Score of 7.5/10, Biogen Inc. is rated "Buy". Clean balance sheet with low leverage (0.4× debt-to-equity). This analysis is based on fundamentals, analyst consensus, and valuation data, and should not be considered financial advice.
What is the analyst price target for BIIB?
The consensus price target for BIIB is $212.51, based on the recommendations of 29 Wall Street analysts. This implies 10.9% upside from the current price of $191.66.
Is BIIB overvalued or undervalued?
Biogen Inc. (BIIB) appears fairly valued at current levels relative to analyst targets and sector peers. It trades at a 12.0× forward P/E ratio. Analysts see 11% upside to their $212.51 consensus target.
When does Biogen Inc. report its next earnings?
Biogen Inc.'s next earnings report is expected on approximately July 30, 2026.
What is Biogen Inc.'s profit margin?
Biogen Inc. has a net profit margin of 13.8%, which is solid for most industries. Its gross margin stands at 78.7%, indicating a high-margin business model.
Is Biogen Inc.'s revenue growing?
Biogen Inc. is reporting modest revenue growth of 1.9%. Earnings are also growing at 31.1%, indicating improving profitability.
How much debt does Biogen Inc. have?
Biogen Inc. has a debt-to-equity ratio of 0.35×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 3.06×, indicating comfortable short-term liquidity.